TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the first quarter ended March 31, 2021. The Company’s un-audited interim financial statements for the three months ended March 31, 2021, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Highlights Revenues f...
TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the quarter and year ended December 31, 2020. The Company’s audited consolidated financial statements for the three months and year ended December 31, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Fin...
TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp (TSX: AHC) (“Apollo” or the “Company”) is pleased to announce that it will be joining the OTC QX marketplace in the United States. Joining the OTC QX will facilitate trading in Apollo’s securities by U.S. investors. The Company expects to complete the process before the end of its first quarter of 2021 and will update the market once the process is complete. Apollo will maintain its primary listing on the Toronto Stock Exchange. Apollo is also pleased to announce that it has retained the services of Hybrid Financial to heighten market and bran...
TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC) (“Apollo” or the “Company”) today announced financial results for the quarter ended September 30, 2020. The Company’s unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Finan...
TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (TSX: AHC) (“Apollo” or the “Company”) announces that Stan Bharti has stepped down as a director of the Company. Charles Wachsberg has agreed to assume Mr. Bharti’s role as Chair of the Board. “We truly value Mr Bharti’s support and his numerous contributions to our Board as Chair. Mr. Bharti has played a key role in the successful turnaround of our business and we are most appreciative and grateful for his efforts” said Charles Wachsberg. In addition, the Company is pleased to announce the appointment of Andrew Schachter to Apollo’s Board...
TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (TSX: AHC) (“Apollo” or the “Company”) is pleased to announce the completion of its previously announced name change from Acasta Enterprises Inc. The Company’s Class B shares began trading under its new name and ticker symbol “AHC”, quoted in Canadian dollars, on the Toronto Stock Exchange at the opening of trading on August 21, 2020. The Company’s new website can be accessed by visiting . No action is required from current shareholders in relation to the name or ticker symbol changes. Cautionary Note Concerning Forward Looking Statements ...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) today announced financial results for the quarter ended June 30, 2020. The Company’s unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Financial Highlights Revenues were $97.8 milli...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted Acasta’s notice to make a normal course issuer bid (the “Bid”) to purchase up to 2,400,628 of the Class B shares of the Company (the “Shares”), being equal to 10% of the Public Float (as defined in the policies of the TSX) which, as at June 4, 2020, consisted of 24,006,282 Shares. All Shares purchased pursuant to the Bid will be made on the open market through the facilities of the TSX and the purchase and payment for the Shar...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) today announced the release of its unaudited interim condensed consolidated financial statements for the three months ended March 31, 2020 and management discussion and analysis (MD&A). These documents will be posted on SEDAR at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Financial Highlights Revenues were $46.6 million for the three months ended March 31, 2020 compared with $41.5 million in the comparative period. The hig...
TORONTO--(BUSINESS WIRE)-- Apollo Beauty Inc. (“ABI”), a company controlled by Richard Wachsberg, the co-Chief Executive Officer of Acasta Enterprises Inc. (“Acasta” or the “Corporation”) has filed an Early Warning Report in accordance with National Instrument 62-103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues, in connection with its purchase of 778,098 Class B shares of the Corporation from an existing shareholder of the Corporation on April 15, 2020 (the “Transaction”). While ABI currently has no other plans or intentions with respect to the Acasta se...
TORONTO--(BUSINESS WIRE)-- Apollo Health Inc. (“AHI”), a company controlled by Charles Wachsberg, the co-Chief Executive Officer of Acasta Enterprises Inc. (“Acasta” or the “Corporation”) has filed an Early Warning Report in accordance with National Instrument 62-103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues, in connection with its purchase of 778,097 Class B shares of the Corporation from an existing shareholder of the Corporation on April 15, 2020 (the “Transaction”). While AHI currently has no other plans or intentions with respect to the Acasta se...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) today announced the release of its audited consolidated financial statements for the three months and year ended December 31, 2019 and management discussion and analysis (MD&A). These documents will be posted on SEDAR at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Financial Highlights Revenues were $41.8 million and $167.1 million for the three months ended and the year ended December 31, 2019 respectively compared with $4...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) today announced the release of its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019 and management discussion and analysis (MD&A). These documents will be posted on SEDAR at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Financial Highlights Acasta reported EBITDA from continuing operations of $3.5 million and $13 million for the three and nine months ended September...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the Corporation”) announced today that its wholly-owned subsidiary, Apollo Health and Beauty Care Inc. (“Apollo”) has been granted a research and development license (the “License”) by Health Canada pursuant to the Cannabis Act. The License will permit Apollo to perform research and development of cosmetics containing CBD pursuant to its research protocol submitted to Health Canada. Research and development by Apollo will be conducted at its state of the art, GMP-certified manufacturing facility located in Toronto. Ap...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) today announced the release of its unaudited condensed consolidated financial statements for the three and six months ended June 30, 2019 and management discussion and analysis (MD&A). These documents will be posted on SEDAR at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Financial Highlights Acasta reported EBITDA from continuing operations of $3.6 million and $9.4 million for the three and six months ended June 30, 2019. ...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the Corporation”) announced today that it: (i) has secured funding for the permanent reduction of its existing bank facility by approximately $15.5 million for a total reduction of debt of $20 million; and (ii) is in the process of establishing a new credit facility with its commercial bank that includes a $50 million asset-based lending facility with a three year term and an $8 million term facility with a one year term. The proposed new facility is planned to be in place by July 31, 2019 and is expected to significant...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the Corporation”) announced today that further to its press release dated June 7, 2019, it has completed a private placement (the “Subsequent Private Placement”) of 2,166,017 Class B Shares of the Corporation (the “Shares”) at a price of $0.68 per share for aggregate gross proceeds of $1,472,891 which is intended to be used to reduce the Corporation’s outstanding bank indebtedness. The private placement was effected at the market price. The Corporation offered to certain of its larger shareholders (the “Offered Shareh...
TORONTO--(BUSINESS WIRE)-- Apollo Health Inc., a company controlled by Charles Wachsberg, the co-Chief Executive Officer of Acasta Enterprises Inc. (“Acasta” or the “Corporation”) has filed an Early Warning Report in accordance with National Instrument 62-103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues, in connection with its acquisition of 2,251,245 Class B shares of Acasta pursuant to a private placement from treasury completed on June 7, 2019, as well as the purchase of an additional 464,636 C...
TORONTO--(BUSINESS WIRE)-- Apollo Beauty Inc., a company controlled by Richard Wachsberg, the co-Chief Executive Officer of Acasta Enterprises Inc. (“Acasta” or the “Corporation”) has filed an Early Warning Report in accordance with National Instrument 62-103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues, in connection with its acquisition of 2,251,245 Class B shares of Acasta pursuant to a private placement from treasury completed on June 7, 2019, as well as the purchase of an additional 464,636 C...
TORONTO--(BUSINESS WIRE)-- Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the Corporation”) announced today that it has completed a private placement (the “Initial Private Placement”) of 4,502,490 Class B Shares of the Corporation (the “Shares”) to corporations controlled by the co-CEOs of the Corporation at a price of $0.68 per share for aggregate gross proceeds of $3,061,693 which is intended to be used to reduce the Corporation’s outstanding bank indebtedness. The private placement was effected at the market price. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.